Log in to save to my catalogue

Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting...

Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_32241173

Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells

About this item

Full title

Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells

Publisher

England: Taylor & Francis

Journal title

Drug delivery, 2020-01, Vol.27 (1), p.530-541

Language

English

Formats

Publication information

Publisher

England: Taylor & Francis

More information

Scope and Contents

Contents

Reconstituted high density lipoprotein (rHDL) has been regarded as a promising brain-targeting vehicle for anti-glioma drugs under the mediation of apolipoprotein A-I (apoA-I). However, some stability issues relating to drug leakage and consequent reduced targeting efficiency in the course of discoidal rHDL (d-rHDL) circulating in blood hinder its...

Alternative Titles

Full title

Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_32241173

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_32241173

Other Identifiers

ISSN

1071-7544

E-ISSN

1521-0464

DOI

10.1080/10717544.2020.1745330

How to access this item